Paulsen leaves Zimmer
This article was originally published in Clinica
Executive Summary
Jeffrey Paulsen has left his post as group president of orthopaedic firm Zimmer's global businesses, effective 20 March. Details of the reasons behind the move, revealed in a filing with the US Securities and Exchange Commission (SEC), were scant, but the company stated: "The separation is not the result of any misconduct." Could it be down to performance? Last month, Zimmer reported flat full-year sales of $4.47 billion, while net profit slipped 1% to $755.0 million (www.clinica.co.uk, 4 February 2013). Mr Paulsen joined the company in January 2010 (www.clinica.co.uk, 14 January 2010); before this, his career covered a range of industries and included a 10-year tenure at one of Zimmer's main rivals, Stryker.